Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on May 01 ’24. In the deal valued at $889.41 per share,250 shares were sold. As a result of this transaction, McCourt Marion now holds 12,931 shares worth roughly $12.37 million.
Then, RYAN ARTHUR F sold 100 shares, generating $89,961 in total proceeds. Upon selling the shares at $899.61, the Director now owns 18,082 shares.
Before that, McCourt Marion sold 250 shares. Regeneron Pharmaceuticals, Inc. shares valued at $241,182 were divested by the EVP Commercial at a price of $964.73 per share. As a result of the transaction, McCourt Marion now holds 13,181 shares, worth roughly $12.61 million.
Bernstein initiated its Regeneron Pharmaceuticals, Inc. [REGN] rating to an Outperform in a research note published on March 12, 2024; the price target was $1125. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid January from “a Sector perform” to “an Outperform”. Deutsche Bank began covering REGN with “Hold” recommendation on November 09, 2023. Raymond James revised its rating on November 03, 2023. It rated REGN as “an Outperform” which previously was an “a Mkt perform”.
Price Performance Review of REGN
On Friday, Regeneron Pharmaceuticals, Inc. [NASDAQ:REGN] saw its stock jump 2.07% to $957.00. Over the last five days, the stock has gained 8.36%. Regeneron Pharmaceuticals, Inc. shares have risen nearly 8.96% since the year began. Nevertheless, the stocks have risen 19.15% over the past one year. While a 52-week high of $998.33 was reached on 02/28/24, a 52-week low of $684.80 was recorded on 01/02/24. SMA at 50 days reached $944.13, while 200 days put it at $868.85. A total of 0.53 million shares were traded, compared to the trading of 1.07 million shares in the previous session.
Levels Of Support And Resistance For REGN Stock
The 24-hour chart illustrates a support level at 936.58, which if violated will result in even more drops to 916.17. On the upside, there is a resistance level at 967.77. A further resistance level may holdings at 978.55. The Relative Strength Index (RSI) on the 14-day chart is 64.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 28.75, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.36%. Stochastics %K at 83.74% indicates the stock is a selling.
